Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

GHRP-2 & CJC-1295 NO DAC Peptide Stack

£27.25£34.05

Buy GHRP-2 CJC-1295 No DAC Peptide Stack

GHRP-2, is well-known for it’s ability to induce significant increases in growth hormone (GH) levels. CJC-1295 No DAC refers to a growth hormone-releasing hormone (GHRH) analogue that can induce sustained growth hormone (GH) elevations. Combining CJC-1295 No DAC and GHRP-2 is a distinct research combination. The synergistic effect amplifies the benefits of both peptides in ways that individual peptide enhancements cannot accomplish.

GHRP-2 5mg | CJC-1295 No DAC 2mg

Buy 10 and get 10% Discount

430 in stock

Description

Buy GHRP-2 CJC-1295 No DAC Peptide Stack

This product is intended for research purposes only. To be used by trained professionals only.

The combination of GHRP-2 CJC-1295 No DAC peptides results in heightened growth hormone (GH) secretion [1] and modifications in metabolic processes that deviate from adipose tissue accumulation. As a result, this leads to an augmentation in lean body mass, a reduction in insulin levels, and enhanced regulation of blood sugar.

GHRP-2

The growth hormone secretagogue receptor (GHSR) agonists, such as GHRP-2, have been widely recognized for their capacity to induce substantial elevations in growth hormone (GH) levels. Due to the very short half-life of most GHSR agonists, the transient nature of these spikes, which exhibit several intriguing and substantial advantages in animal models, is also seen.

Visit the main GHRP-2 category page at Direct Peptides America for further information on available products, research, benefits and potential side effects.

CJC-1295 no DAC

CJC-1295 no DAC peptide is a growth hormone-releasing hormone (GHRH) analogue that has the ability to induce prolonged elevations in growth hormone (GH) levels [2].

For comprehensive details on our range of products, research insights, benefits, and potential side effects, explore the CJC-1295 no DAC category page at Direct Peptides America.

Consequently, there is a sustained elevation in both basal and peak growth hormone (GH) levels over an extended period, although the magnitude of this rise is considerably lower compared to the GH surge induced by growth hormone secretagogue receptor (GHSR) agonists [3].

Furthermore, animal studies have shown that GHRH analogues are prone to interference from somatostatin, which can effectively counterbalance the elevation in GH levels [4].


GHRP-2 CJC-1295 No DAC Synergistic Effects

Ongoing America research is being conducted to explore the potential synergistic effects of combining GHSR agonists and GHRH analogues in order to optimize their respective benefits. The combination of GHRP-2 CJC-1295 No DAC is a specific research amalgamation, the synergistic effect amplifies the advantages of both peptides in manners that individual augmentation of either peptide cannot achieve.

The amalgamation of the GHRP-2 CJC-1295 No DAC peptides yields enhanced growth hormone (GH) secretion and alterations in metabolic processes that divert from the accumulation of adipose tissue. Consequently, this leads to an increase in lean body mass, a decrease in insulin levels, and improved regulation of blood sugar.

Shop ALL peptide stacks here from Direct Peptides America.


Key Features of GHRP-2 CJC-1295 No DAC Peptide Stack

  • Synergistic Effect: Combines GHRP-2 and CJC-1295 No DAC for enhanced growth hormone secretion.
  • Pituitary Stimulation: GHRP-2 actively promotes the pituitary gland to increase growth hormone release.
  • Metabolic Benefits: Supports muscle growth, fat loss, and overall metabolic activity.
  • Endogenous Hormone Elevation: Prolonged use can lead to significant increases in endogenous growth hormone levels.
  • Research Versatility: Suitable for studies on body composition, exercise recovery, and anti-aging effects.
  • Insulin Regulation: Potential to aid in the regulation of insulin and glucose metabolism.
  • Flexible Dosing Options: Available in various forms to accommodate tailored experimental designs.
  • Important Research Focus: Valuable for advancing understanding in endocrinology and sports performance.

Shipping and Handling

Shipping and handling of the GHRP-2 (5mg) and CJC-1295 No DAC (2mg) Peptide Stack are conducted with strict adherence to safety protocols, ensuring that all products are securely packaged and delivered in compliance with regulatory standards for research materials.

Storage Guidelines

To maintain the integrity and stability of the GHRP-2 (5mg) and CJC-1295 No DAC (2mg) Peptide Stack, it is essential to store the peptides in a cool, dry place at temperatures between 2°C and 8°C, and to protect them from light and moisture until they are ready for use.


Reconstitution of GHRP-2 (5mg) and CJC-1295 No DAC (2mg) Peptide Stack

Reconstituting the GHRP-2 (5mg) and CJC-1295 No DAC (2mg) peptide stack involves ensuring sterile equipment, carefully adding sterile diluent such as bacteriostatic water to each vial, and gently swirling to dissolve the peptides. After reconstitution, they can be combined in a syringe for simultaneous use. Visit the peptide supplies page here at Direct Peptides America for all your reconstitution accessories.

It’s crucial to store the reconstituted peptides in a refrigerator at 2°C to 8°C and use them within the recommended timeframe to ensure stability and effectiveness. Following these steps will help maintain optimal efficacy for research or clinical applications.


References:

[1] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

[2] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, and R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology, Endocrinology and Metabolism, Volume 291, Issue 6, December 2006, Pages E1290-E1294.

[3] B Laferrère, C Abraham, C D Russell, and C Y Bowers (2005) Growth Hormone Releasing Peptide -2 (GHRP-2), like ghrelin, increases food intake in healthy men – Journal of Clinical Endocrinology and Metabolism, 2005 Feb, Volume 90 (Issue 2), Pages 611–614.

[4] C Hirotani, Y Oki, K Ukai, T Okuno, S Kurasaki, T Ohyama, N Doi, K Sasaki, K Ase (2005) ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF – Naunyn Schmiedebergs Archives of Pharmacology, 2005 Jan, Volume 371 (Issue 1), Pages 54-60.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our America Direct Peptides website: https://america.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY GHRP-2 CJC-1295 No DAC Peptide Stack ONLINE today From America Direct Peptides

You may also like…